Production (Stage)
Seres Therapeutics, Inc.
MCRB
$7.05
-$0.04-0.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 91.11% | -53.92% | -6.19% | -35.93% | -13.11% |
| Total Receivables | 33.51% | -- | -- | 150.75% | -- |
| Inventory | -- | -- | -- | 26.26% | -- |
| Prepaid Expenses | -23.14% | -4.77% | -5.14% | 39.71% | -42.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 70.86% | -46.97% | -51.14% | -9.64% | -5.83% |
|
|
|||||
| Total Current Assets | 70.86% | -46.97% | -51.14% | -9.64% | -5.83% |
| Net Property, Plant & Equipment | -3.28% | -3.18% | -21.14% | -2.97% | 15.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -15.85% | -79.88% | 0.18% | -31.75% |
| Total Assets | 17.43% | -21.78% | -44.44% | -5.72% | -4.83% |
|
|
|||||
| Total Accounts Payable | -46.85% | -50.58% | 71.64% | -7.86% | 43.34% |
| Total Accrued Expenses | -41.97% | -39.50% | -59.07% | 7.92% | 78.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.32% | 3.93% | -9.23% | 4.10% | 58.10% |
| Total Finance Division Other Current Liabilities | -21.77% | -41.84% | -40.16% | 15.07% | -33.77% |
| Total Other Current Liabilities | -21.77% | -41.84% | -40.16% | 15.07% | -33.77% |
| Total Current Liabilities | -24.01% | -36.42% | -40.13% | 9.96% | -0.18% |
|
|
|||||
| Total Current Liabilities | -24.01% | -36.42% | -40.13% | 9.96% | -0.18% |
| Long-Term Debt | -- | -- | -- | 0.48% | 0.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.97% | -2.70% | -15.52% | -2.33% | 12.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.10% | -61.09% | -95.13% | -0.08% | -12.93% |
| Total Liabilities | -9.77% | -18.60% | -62.13% | 1.95% | -0.61% |
|
|
|||||
| Common Stock & APIC | 0.40% | 0.56% | 2.30% | 0.58% | 2.71% |
| Retained Earnings | 3.34% | -1.62% | 8.44% | -3.23% | -4.10% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 266.11% | -42.37% | 127.47% | -45.76% | -33.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 266.11% | -42.37% | 127.47% | -45.76% | -33.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 266.11% | -42.37% | 127.47% | -45.76% | -33.18% |
|
|
|||||